Literature DB >> 6538004

Myasthenia gravis: prolonged treatment with steroids.

A Sghirlanzoni, D Peluchetti, R Mantegazza, F Fiacchino, F Cornelio.   

Abstract

We have evaluated chronic corticosteroid treatment in 60 myasthenic patients; 92% were followed for more than 3 years and 82% longer than 4 years. Improvement was noted in 72% of the patients. The best results were seen in those whose symptoms started after the age of 40 years. There was a correlation between the starting dose of prednisone and the rate of improvement. Complete withdrawal of steroids was possible only for 3 patients.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6538004     DOI: 10.1212/wnl.34.2.170

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  28 in total

Review 1.  Current Treatment, Emerging Translational Therapies, and New Therapeutic Targets for Autoimmune Myasthenia Gravis.

Authors:  Jeffrey T Guptill; Madhu Soni; Matthew N Meriggioli
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

2.  Efficacy of intranasal administration of neostigmine in myasthenic patients.

Authors:  A Sghirlanzoni; D Pareyson; C Benvenuti; G Cei; V Cosi; M Lombardi; M Nicora; R Ricciardi; F Cornelio
Journal:  J Neurol       Date:  1992-03       Impact factor: 4.849

Review 3.  Treatment of myasthenia gravis: focus on pyridostigmine.

Authors:  Lorenzo Maggi; Renato Mantegazza
Journal:  Clin Drug Investig       Date:  2011-10-01       Impact factor: 2.859

4.  Anti AChR antibody: relevance to diagnosis and clinical aspects of myasthenia gravis.

Authors:  R Mantegazza; D Pareyson; F Baggi; P Romagnoli; D Peluchetti; A Sghirlanzoni; F Cornelio
Journal:  Ital J Neurol Sci       Date:  1988-04

5.  Azathioprine as a single drug or in combination with steroids in the treatment of myasthenia gravis.

Authors:  R Mantegazza; C Antozzi; D Peluchetti; A Sghirlanzoni; F Cornelio
Journal:  J Neurol       Date:  1988-11       Impact factor: 4.849

6.  Managing patients who have myasthenia gravis.

Authors:  T R Johns
Journal:  West J Med       Date:  1985-06

7.  Thymectomy for myasthenia gravis: a fourteen-year experience.

Authors:  A Sghirlanzoni; R Mantegazza; D Peluchetti; F Fiacchino; L Morandi
Journal:  Ital J Neurol Sci       Date:  1985-12

8.  A randomised clinical trial comparing prednisone and azathioprine in myasthenia gravis. Results of the second interim analysis. Myasthenia Gravis Clinical Study Group.

Authors: 
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-11       Impact factor: 10.154

Review 9.  Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity.

Authors:  Matthew N Meriggioli; Donald B Sanders
Journal:  Lancet Neurol       Date:  2009-05       Impact factor: 44.182

10.  A short plasma exchange protocol is effective in severe myasthenia gravis.

Authors:  C Antozzi; M Gemma; B Regi; E Berta; P Confalonieri; D Peluchetti; R Mantegazza; F Baggi; M Marconi; F Fiacchino
Journal:  J Neurol       Date:  1991-04       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.